|
| |
affymax email Pages on BioPortfolio:
Biotechnology News clinical phase hematid. affymax. dmc. crf. ckd ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Affymax
Affymax - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/227-Affymax.html...
|
Biotechnology News Nektar eps1. morel. 3345. esa. 683. profit1. Search
Affymax to Webcast Analyst and Investor Event on November 20, 2008 ... Affymax Completes Enrollment in EMERALD 1, the Third of Four Phase 3 Clinical Trials ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Affymax finance
Affymax finance - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/227-Affymax/finance...
|
Biotechnology News Anemia Refractory humax. genmab. ofatumumab ...
Affymax Completes Enrollment in EMERALD 1, the Third of Four Phase 3 ... Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Affymax - Profile
8 Nov 2008 ... View the current Affymax Page on BioPortfolio.com ... Affymax, Inc. is a drug discovery powerhouse uniquely positioned to leverage over a ...
http://www.bioportfolio.com/biocorporate/227-Affymax.pdf...
|
Biotechnology News Urologic atkinson. anemia. meredith. asn ...
Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrol PALO ALTO, Calif. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - affymax
Affymax - Entry on Bioportfolio's Biocorporate Database. ... Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of . ...
http://www.bioportfolio.com/search/affymax.html...
|
Biotechnology News Anemia Hemolytic Autoimmune terpolym. mhc ...
Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure ... Affymax to Webcast Analyst and Investor Event on November 20, 2008
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - AFFYMAX
Affymax - Entry on Bioportfolio's Biocorporate Database. ... Biotechnology News Heart Failure Congestive hematid. affymax . ...
http://www.bioportfolio.com/search/AFFYMAX.html...
|
Results from other life science and pharmaceutical sites:
Affymax, Inc. - Home
Affymax is a biopharmaceutical company creating novel approaches for improving patient care for serious and life-threatening conditions in kidney disease ...
http://www.affymax.com/...
|
BioSpace - Affymax, Inc. News, Search Jobs, Events
Affymax, Inc. (AFFY) Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, ...
http://www.biospace.com/company_profile.aspx?CompanyId=1270...
|
Affymax, Inc. - Management
The Affymax management team has extensive experience in the biotechnology and pharmaceutical industries. Members of this proven team have been instrumental
...
http://www.affymax.com/about_management.html...
|
Affymax® and Takeda Recognized for Innovative Global Agreement to ...
19 Oct 2007 ... PALO ALTO, Calif., and Osaka, Japan, October 17, 2007 – Affymax, ... The Affymax and Takeda collaboration was recognized by the LES as one ...
http://www.takeda.com/press/article_28348.html...
|
Affymax, Inc. - Career Opportunities
Affymax has both the benefit of an experienced, cohesive employee team and ... Affymax offers challenging and rewarding positions to qualified and motivated
...
http://www.affymax.com/careers_careeropp.html...
|
Affymax Completes Enrollment in Phase 3 Program for Hematide in ...
Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3
...
http://biz.yahoo.com/bw/081117/20081117005525.html?.v=1...
|
Affymax, Inc. - Pipeline
At Affymax, we are leveraging our proven discovery platform to create a ... Affymax has active research projects for novel peptides that compete with the
...
http://www.affymax.com/research_pipeline.html...
|
Takeda and Affymax Provide Clinical Development Update for ...
29 Aug 2008 ... Takeda and Affymax continue to be encouraged by the potential of bringing Hematide™, a convenient, once monthly treatment option, ...
http://www.takeda.com/press/article_30596.html...
|
Affymax, Inc. - Company Overview
Affymax is a biopharmaceutical company that is developing a pipeline of synthetic ... Affymax’s objective is to discover, develop and commercialize
novel ...
http://www.affymax.com/about_overview.html...
|
Affymax and Takeda Announce Agreement To Develop and Commercialize ...
(February 12), and OSAKA, Japan (February 13), 2006 −Affymax, Inc. (Affymax) and Takeda Pharmaceutical Company Limited (Takeda) today announced that the ...
http://www.takeda.com/press/article_1183.html...
|
|
